~ By Anand Parikh 

 

Disclaimer: The contents of this article are based on a non-medical author's reserach and review, and in no way claim to be medical or clinical advice. The reader is responsible for verification of the information provided here.

An expert Plastic and Reconstructive surgeon at a new hospital in Hyderabad recently counselled a breast cancer patient about her reconstruction options. The patient chose a pedicled flap andsubsequently went home without the gold-standard DIEP Flap reconstruction.

Why did the patient choose pedicled flap over a DIEP flap? Was it the failure rate? The cost? Duration of the surgery? Long term outcome? Across more than 50,000 published DIEP flap cases, total flap loss at expert centres runs between 0.5% and 2%. The LMIC pooled rate from sub-Saharan Africa sits at 11%.

This guide is for surgeons who are building, running, or scaling a DIEP programme in India or anywhere with resource constraints. It covers the real numbers, the root causes of failure, the protocols that work, and the training and instrumentation decisions that matter most.

<2% Total flap loss at expert centres

~11% LMIC pooled failure rate

94% Salvage rate within 24 hours

71% Indian women prefer DIEP when informed

Section 1 — What the evidence actually says about failure rates

Section 2 — Why flaps fail: the six-domain framework

Flap failure is never random. Across 44,031 flaps in Shen's 2021 systematic review, 59.5% of failures were caused by venous thrombosis and 27.9% by arterial occlusion. The root causes cluster into six domains:

Domain	Key Evidence
Technical factors	Ischaemia >99.5 min → fat necrosis ↑↑; backwalling error → anastomotic thrombosis; poor perforator selection → Zone IV ischaemia
Team & learning curve	First 30 cases: 40% complications vs 13.8% thereafter; single-team adds ~40 min ischaemia; operative time >7 h = 16% more complications per hour
Monitoring failure	q4–q8 h ward checks (LMIC) vs q1 h (HIC); salvage 93.8% within 24 h → 0% after Day 4; no 24/7 OR = automatic flap loss
Patient factors	Smoking: fat necrosis OR 3.5×; BMI ≥40: OR 1.71; prior radiation: OR 4.05; obese smoker + immediate + RT: OR 12.68
Infrastructure	No patient warming → vasospasm ↑; sub-optimal instruments → backwalling risk; no coupler → hand-sewn venous (2× more time)
Volume & system	<10 DIEP/yr: 5.72× higher flap loss (Japan registry, 19,482 flaps); no outcomes registry = blind to own failure rate

Section 3 — The salvage window: your most important metric

Section 4 — Evidence-based intraoperative protocol

Protocol Step	Evidence / Impact
✅ Venous coupler for end-to-end anastomosis	Anastomosis time: 32.2 → 7.5 min; thrombosis 1.5% vs 2.3% hand-sewn
✅ TXA 1g IV pre-incision + 1g at closure + topical 3% to abdomen	Reduced abdominal complications; 0% anastomotic thrombosis in TXA arm (Lardi 2018)
✅ Goal-directed fluids: 5–6 mL/kg/hr	Liberal fluids increase fat necrosis from 13.6% to 37.1% (Sarik 2021)
✅ Patient warming from induction; core temp ≥36°C	Hypothermia → vasospasm → anastomotic failure
✅ Two-team simultaneous operating	Saves 40–60 minutes ischaemia time
✅ IMA as preferred recipient artery	2.36 mm vs 1.79 mm thoracodorsal; better calibre match
✅ Papaverine/verapamil for vessel spasm	NOT lidocaine alone — inadequate vasodilatory effect
❌ Avoid prolonged norepinephrine infusion	Significantly increases total flap loss (Larcher, Microsurgery 2025, n=335)
❌ Avoid liberal fluid regimens	Fat necrosis 13.6% (GDFT) vs 37.1% (liberal) — Sarik 2021

Section 5 — Patient selection at new programmes

The most powerful risk-reduction tool at a new programme is not better equipment — it is stricter patient selection. For your first 25 cases: BMI 18–30, non-smoker, no prior radiation, delayed reconstruction only. The synergy OR of 12.68 for obese active smokers undergoing immediate reconstruction in the setting of planned radiotherapy is not survivable for a programme without established monitoring infrastructure.

✅ Ideal candidate (first 25 cases) • BMI 18–30 • Non-smoker or quit >4 weeks • No prior abdominal surgery • Delayed reconstruction (6–12 months) • No prior abdominal radiation

⚠️ Red flags — defer or discuss carefully • Active smoker (fat necrosis OR 3.5×) • BMI ≥40 (complications OR 1.71) • Prior/planned radiotherapy (OR 4.05) • Immediate reconstruction + planned RT • Poor social support at home

Section 6 — Instrumentation: the often-overlooked variable

Surgeon training and protocols receive most of the attention in DIEP outcome literature. Instrumentation quality receives far less — yet every instrument in the microsurgical set is a potential source of failure. An uncalibrated clamp that crushes the vessel lumen causing risk of thrombosis, or a clamp that collapses the vessel walls instead of everting them creates a backwalling risk on every posterior wall suture. A needle holder that does not let the suture slide easily or holds the needle at an incorrect angle under magnification translates directly to anastomosis tension and lumen narrowing.

Section 7 — Building a DIEP programme in India: minimum viable setup

Item	Priority	Estimated Cost (India)
Operating Microscope (refurbished Zeiss/Leica or new mid-range)	MUST HAVE	₹15–30 lakh
Patient Warming (Bair Hugger equivalent)	MUST HAVE	₹3–8K per case
Handheld 8 MHz Doppler ×2	MUST HAVE	₹12–18K each
Microvascular Coupler System	MUST HAVE	₹1.2L setup + ₹8–15K/case
HDU with q1h flap-trained nursing	MUST HAVE	Training investment only
Colour Duplex Ultrasound (non-inferior to CTA, Bajus RCT 2023)	HIGHLY RECOMMENDED	₹8–25L (one-time)
FLIR ONE Pro Thermography (smartphone-based)	USEFUL ADD-ON	₹30K one-time

Sources: Gill Ann Plast Surg 2004; DGPRÄC Registry Cancers 2021 (n=4,577); Marwah Indian J Plast Surg 2024 (n=35); Shen JRM 2021 (n=44,031); Anbazhagan PRS Global Open 2021 (n=10,299); Nair JCO Glob Oncol 2021 (n=492); Sarik 2021; Lardi GS 2018; Larcher Microsurgery 2025; Bajus JPRAS RCT 2023; Japan Nationwide Registry Onoda 2023 (n=19,482).